Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 02/03/2022.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques fabriquées localement :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | Date de courrier |
1 | OSMOLAX | POLYETHYLENE GLYCOL | 10 g | Poudre pour solution orale | B/10 | ADWYA | C | N | 01/02/2022 |
2 | NAFTOR | NAFTIDROFURYL | 100 mg | Gélule | B/50 | ACT PHARMA | I | V | 15/02/2022 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | Date de courrier |
1 | EVOCOR 1.25 | BISOPROLOL | 1.25 mg | Comprimé pelliculé | B/30 | PHILADELPHIA PHARMA | E | N | 24/11/2020 |
2 | FEROVEN | FER | 100 mg / 5ml | Solution injectable pour perfu | B/5/5 ML | SAIPH | E | V | 06/01/2022 |
3 | VENTOL | SALBUTAMOL | 2.5mg/2.5ml | Solution pour inhalation | B/10 unidoses de 2.5 ml | UNIMED | E | N | 26/01/2022 |
4 | ATROPINE SAIPH | ATROPINE | 0.25 mg/ ml | Solution injectable | B/10/1 ML | SAIPH | V | V | 01/02/2022 |
5 | PLAVIX | CLOPIDOGREL | 75 mg | Comprimé pelliculé | B/28 | SANOFI AVENTIS PHARMA TUNISIE | E | V | 01/02/2022 |
6 | PECTORAL ADULTE SANS SUCRE | CODEINE | Solution buvable | Fl/200 ml | SIPHAT | C | V | 01/02/2022 | |
7 | FLUVASTA | FLUVASTATINE | 40 mg | Gélule | FL/30 | TAHA PHARMA | E | V | 01/02/2022 |
8 | MEDICAINE 3% SANS VASOCONSTRIC | MEPIVACAINE | 3% | Solution injectable | B/50 CARPULES/1.8ML | LES LABORATOIRES MEDIS | E | V | 01/02/2022 |
9 | MEDICAINE 2% AVEC ADRENALINE | MEPIVACAINE+ADRENALINE | Solution injectable | B/50 CARPULES/1.8ML | LES LABORATOIRES MEDIS | E | V | 01/02/2022 | |
10 | BETANYL | TERBUTALINE | 5 mg/2ml | Solution pour inhalation | B/5 sachets de 10 unidoses/2ml | UNIMED | E | V | 01/02/2022 |
11 | MEDISCAN | IOHEXOL | 300 mg I/ml | Solution injectable | FL/50 ml | LES LABORATOIRES MEDIS | E | N | 02/02/2022 |
12 | MEDISCAN | IOHEXOL | 300mg I/ml | Solution injectable | FL/100ml | LES LABORATOIRES MEDIS | E | N | 02/02/2022 |
13 | MEDISCAN | IOHEXOL | 350 mg/ml | Solution injectable | FL/100ML | LES LABORATOIRES MEDIS | E | N | 02/02/2022 |
14 | MEDISCAN | IOHEXOL | 350mg I/ml | Solution injectable | FL/50ml | LES LABORATOIRES MEDIS | E | N | 02/02/2022 |
15 | TRIPYLORI | BISMUTH +METRONIDAZOLE+TETRACYCLINE | 125mg/125mg/140mg | Gélule | B/1fl/120 | SAIPH | E | N | 09/02/2022 |
16 | CYTOKAR | CARBOPLATINE | 10 mg/ml | Solution injectable | FL/45 ml | CYTOPHARMA | V | N | 15/02/2022 |
17 | DACARBAZINE NEAPOLIS | DACARBAZINE | 100 mg | Poudre pour solution injectabl | B/1 FL | NEAPOLIS PHARMA | V | N | 15/02/2022 |
18 | DACARBAZINE NEAPOLIS | DACARBAZINE | 100 mg | Poudre pour solution injectabl | B/10 FL | NEAPOLIS PHARMA | V | N | 15/02/2022 |
19 | DACARBAZINE NEAPOLIS | DACARBAZINE | 200 mg | Poudre pour solution injectabl | B/1 FL | NEAPOLIS PHARMA | V | N | 15/02/2022 |
20 | DACARBAZINE NEAPOLIS | DACARBAZINE | 200 mg | Poudre pour solution injectabl | B/10 FL | NEAPOLIS PHARMA | V | N | 15/02/2022 |
21 | LINCOJECT | LINCOMYCINE | 600 mg/2ml | Solution injectable | B/100/2 ML | STERIPHARM | E | N | 15/02/2022 |
22 | LINCOJECT | LINCOMYCINE | 600 mg/2ml | Solution injectable | B/1 Ampoule/2 ML | STERIPHARM | E | N | 15/02/2022 |
23 | PREGABALINE SIMED | PREGABALINE | 20 MG/ML | Solution buvable | FL/473ML | SIMED | V | N | 15/02/2022 |
24 | DIACURE NOURRISSON | RACECADOTRIL | 10 mg | Poudre pour solution orale | B/16 sachets | SAIPH | I | N | 15/02/2022 |
25 | DIACURE ENFANT | RACECADOTRIL | 30 mg | Poudre pour solution orale | B/30 sachets | SAIPH | I | N | 15/02/2022 |
26 | TOFACITINIB NEAPOLIS | TOFACITINIB | 5 MG | Comprimé pelliculé | B/60 | NEAPOLIS PHARMA | E | N | 15/02/2022 |
Spécialités Pharmaceutiques importées
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | LOXEN LP | NICARDIPINE | 50 MG | GELULE LP | B/60 | CARDIXO | E | N | 01/10/2021 |
2 | TERLIPRESSINE EVER VALINJECT | TERLIPRESSINE | 0,2 mg/ml | Sol Injectable | B/5AP | EVER VALINJECT GMBH | E | N | 02/12/2021 |
3 | TECENTRIQ | ATEZOLIZUMAB | 1200 mg | sol inj p Perfusion | B/1FL/20ML | ROCHE SUISSE | V | N | 15/12/2021 |
4 | FORTACIN | LIDOCAINE+PRILOCAINE | 150 MG+50 MG*/ML | SOLUTION EXTERNE | FL/5 ML | RECORDATI | C | N | 29/12/2021 |
5 | LUCENTIS | RANIBIZUMAB | 10MG/ML | SOL INJ | B/1FL | NOVARTIS PHARMA SCHWEIZ AG | E | V | 18/01/2022 |
6 | PERGOVERIS | FSH+LH | 150 UI/75 UI | PDRE PR PREP INJ | B/1FL | MERCK EUROPE B.V | E | N | 19/01/2022 |
7 | XALKORI | CRIZOTINIB | 200 MG | GELULE | FL/60 | PF PRISM/PFIZER NETHELAND | V | V | 19/01/2022 |
8 | XALKORI | CRIZOTINIB | 250 MG | GELULE | FL/60 | PF PRISM/PFIZER NETHELAND | V | V | 19/01/2022 |
9 | GONAL-F | FSH | 75 UI (5.5 mcg) | PDRE PR PREP INJ | B/1FL | MERCK EUROPE B.V | E | N | 19/01/2022 |
10 | OVITRELLE | GONADOTROPHINE CHORIONIQUE | 250 MCG/0.5ml | SOL INJ | B/1SER | MERCK EUROPE B.V | E | N | 19/01/2022 |
11 | TRIMBOW | BECLOMETHASONE+FORMOTEROL+GLYCOPYRRONIUM | 87 µg/5 µg/9 µg | SOL PR INH | FL/120 doses | CHIESI FARMACEUTICI S.p.A | E | N | 20/01/2022 |
12 | VOTRIENT | PAZOPANIB | 400 mg | COMP PEL | FL/30 | NOVARTIS EUROPHARM LIMITED IRLANDE | V | N | 25/01/2022 |
13 | VOTRIENT | PAZOPANIB | 200 mg | COMP PEL | FL/30 | NOVARTIS EUROPHARM LIMITED IRLANDE | V | N | 25/01/2022 |
14 | HUMIRA | ADALIMUMAB | 80 mg/0.8 ml | SOL INJ | B/1 stylo pré-rempli/0.8 ml | ABBVIE DEUTSCHLAND Gmbh and Co.KG | E | N | 01/02/2022 |
15 | HUMIRA | ADALIMUMAB | 40 mg/0.4ml | SOL INJ | B/2 stylo pré-rempli/0.4 ml | ABBVIE DEUTSCHLAND Gmbh and Co.KG | E | N | 01/02/2022 |
16 | HUMIRA | ADALIMUMAB | 20 mg/0.2 ml | SOL INJ | B/1 seringue pré-rempli/0.2ml | ABBVIE DEUTSCHLAND Gmbh and Co.KG | E | N | 01/02/2022 |
17 | OXYNORM | OXYCODONE | 20mg/2ml | SOL INJ | B/5/2ml | Napp Pharmaceuticals Limited | V | N | 09/02/2022 |
18 | ARCHIFAR | MEROPENEME | 500 mg | PDRE PR PREP INJ | B/1FL | MEDOCHEMIE LTD | E | N | 16/02/2022 |
19 | ZEFFIX | LAMIVUDINE | 100 mg | COMP PEL | B/28 | GlaxoSmithKline (Ireland) Limited | E | N | 21/02/2022 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | CHIBRO-PROSCAR | FINASTERIDE | 5 MG | COMP PEL | B/28 | Organon France | I | T | 02/12/2021 |
2 | DUOFILM | ACIDE LACTIQUE+ACIDE SALICYLIQUE | SOL EXT | FL/15ML | Laboratoires EUROGENERICS (EG LABO) | C | T | 09/12/2021 | |
3 | LETROZOLE PHARMACARE | LETROZOLE | 2.5 mg | COMP | B/30 | PHARMACARE PREMIUM LIMITED | N | 16/12/2021 | |
4 | YUPELRI | REVEFENACIN | 175 µg/3ml | SOL PR INH | B/30 | Mylan Ireland Limited | N | 16/12/2021 | |
5 | STEROGYL 15 "H" | ERGOCALCIFEROL | 600 000 UI/1.5 ml | SOL INJ | B/1 amp | DESMA Pharma | E | N | 16/12/2021 |
6 | AZYTRA | AZITHROMYCINE | 250mg | CAPS MOLLE | B/6 | BEIT JALA Pharmaceutical Co | E | N | 16/12/2021 |
7 | IRINOTECAN HOSPIRA | IRINOTECAN | 20 mg/ml | SOL INJ PR PERF | B/1 FL | HOSPIRA UK Limited | V | T | 16/12/2021 |
8 | CELESTENE | BETAMETHASONE | 2 MG | COMP DISP SEC | FL/20 | Organon France | E | T | 20/12/2021 |
9 | NOVOSEVEN | FACTEUR VII A | 1 MG | PDRE PR PREP INJ | B/1F | NOVONORDISK A/S BAGSVAERD | V | V | 06/01/2022 |
10 | NOVOSEVEN | FACTEUR VII A | 2 MG | PDRE PR PREP INJ | B/1F | NOVONORDISK A/S BAGSVAERD | V | V | 06/01/2022 |
11 | NOVOSEVEN | FACTEUR VII A | 5 MG | PDRE PR PREP INJ | B/1F | NOVONORDISK A/S BAGSVAERD | V | V | 06/01/2022 |
12 | FEROVEN | FER | 100 mg / 5ml | Solution injectable pour perfu | B/5/5 ML | SAIPH | V | V | 06/01/2022 |
13 | HEMLIBRA | EMICIZUMAB | 30mg/ml | sol pour inj | B/1Fl /1ml | ROCHE Suisse | V | V | 06/01/2022 |
14 | HEMLIBRA | EMICIZUMAB | 150mg/ml | sol pour inj | B/1Fl /1ml | ROCHE Suisse | V | V | 06/01/2022 |
15 | HEMLIBRA | EMICIZUMAB | 60 mg/0.4 ml | sol pour inj | B/1Fl /3ml | ROCHE Suisse | V | V | 06/01/2022 |
16 | HEMLIBRA | EMICIZUMAB | 105mg/0.7ml | solpourinj | B/1Fl /3ml | ROCHE Suisse | V | V | 06/01/2022 |
17 | NIVESTIM | FILGRASTIM | 30 MU/0.5 ml | SOL INJ | B/5SER | PFIZER Europe MA EEIG | V | T | 11/01/2022 |
18 | NIVESTIM | FILGRASTIM | 48 MU/0.5 ml | SOL INJ | B/5SER | PFIZER Europe MA EEIG | V | T | 11/01/2022 |
19 | KADCYLA | TRASTUZUMAB | 100 MG | PDRE PR SOL PR PF | B/1FL /15ml | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | V | N | 19/01/2022 |
20 | DYSPORT | TOXINE BOTULIQUE | 500u | pdr pour prep inj | B/1FL | IPSEN | V | V | |
21 | PMS CLONAZEPAM | CLONAZEPAM | 2mg | cp sécable | Fl/100 | Pharmascience | V | V | |
22 | KADCYLA | TRASTUZUMAB | 160 MG | PDRE PR SOL PR PF | B/1FL /20ml | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | V | N | 25/01/2022 |
23 | LENVIMA | MESILATE DE LENVATINIB | 4 MG | GELULE | B/30 | EISAI GmbH | V | N | 25/01/2022 |
24 | LENVIMA | MESILATE DE LENVATINIB | 10 MG | GELULE | B/30 | EISAI GmbH | V | N | 25/01/2022 |
25 | FIXAPROST | LATANOPROST+TIMOLOL | 50 µg/ml | COLLYRE | B/30 unidoses | THEA | E | N | 25/01/2022 |
26 | REAGILA | CHLORHYDRATE DE CARIPRAZINE | 1.5 mg | GELULE | B/30 | GEDEON RICHTER | N | 25/01/2022 | |
27 | REAGILA | CHLORHYDRATE DE CARIPRAZINE | 3 mg | GELULE | B/30 | GEDEON RICHTER | N | 25/01/2022 | |
28 | REAGILA | CHLORHYDRATE DE CARIPRAZINE | 4,5 mg | GELULE | B/30 | GEDEON RICHTER | N | 25/01/2022 | |
29 | REAGILA | CHLORHYDRATE DE CARIPRAZINE | 6 mg | GELULE | B/30 | GEDEON RICHTER | N | 25/01/2022 | |
30 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 400µg/4ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
31 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 200µg/2ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
32 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 1000µg/10ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
33 | VESSEL | SULODEXIDE | 600UL | SOL INJ | B/10/2ML | ALFASIGMA | I | V | 01/02/2022 |
34 | VESSEL | SULODEXIDE | 250UL | SOL INJ | B/50 | ALFASIGMA | I | V | 01/02/2022 |
35 | JARDIANCE | EMPAGLIFLOZINE | 10 MG | COMP PEL | B/30 | BOEHRINGER INGELHEIM | E | V | 01/02/2022 |
36 | JARDIANCE | EMPAGLIFLOZINE | 25 MG | COMP PEL | B/30 | BOEHRINGER INGELHEIM | E | V | 01/02/2022 |
37 | DEXMEDETOMIDINE EVER PHARMA | Dexmedetomidine | 1000µg/10ml | SOL INJ PR PERF | B/5FL | EVER Valinject GmbH | N | 01/02/2022 | |
38 | SINGULAIR | MONTELUKAST | 10 mg | COMP | B/28 | ORGANON N.V HOLLLANDE | E | T | 01/02/2022 |
39 | SINGULAIR | MONTELUKAST | 5 mg | COMP | B/28 | ORGANON N.V HOLLLANDE | E | T | 01/02/2022 |
40 | CUROSURF | PHOSPHOLIPIDES TOTAUX | 120MG/1,5ML | SUSP | FL/1,5%M | CHIESI | V | V | 01/02/2022 |
41 | PULMICORT | BUDESONIDE | 0,5MG/0,2ML | SOL PR INH | 20 UNIDOSES | ASTRA ZENECA | E | V | 01/02/2022 |
42 | VIACORAM | PERINDOPRIL ARGININE+ AMLODIPINE | 7 mg/ 5 mg | COMP | PILULIER | SERVIER | E | R | 01/02/2022 |
43 | VIACORAM | PERINDOPRIL ARGININE+ AMLODIPINE | 3,5 mg/2,5 mg | COMP | PILULIER | SERVIER | E | R | 01/02/2022 |
44 | ZANIDIP | LERCANIDIPINE | 10 MG | COMP PEL SEC | B/30 | BOUCHARA RECARDATI | E | V | 01/02/2022 |
45 | UPTRAVI | SELEXIPAG | 200µG | COMP PEL | B/140 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
46 | UPTRAVI | SELEXIPAG | 200µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
47 | UPTRAVI | SELEXIPAG | 400µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
48 | UPTRAVI | SELEXIPAG | 600µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
49 | UPTRAVI | SELEXIPAG | 800µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
50 | UPTRAVI | SELEXIPAG | 1000µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
51 | UPTRAVI | SELEXIPAG | 1200µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
52 | UPTRAVI | SELEXIPAG | 1400µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |
53 | UPTRAVI | SELEXIPAG | 1600µG | COMP PEL | B/60 | Janssen-Cilag International N.V | V | N | 11/02/2022 |